U.S. outpatient prescriptions for hydroxychloroquine and ivermectin increased 2- to 10-fold above pre-pandemic rates, respectively, to treat COVID-19, despite strong evidence disproving their ...

Kennedy Jr. for the head of Health and Human Services, medical community members rebuked the American Academy of Pediatrics ...

As COVID-19 continues to evolve into new variants, it is clear that the virus is here to stay. With vaccines no longer at the center of public discourse and their safety is in question against ...

As COVID-19 surged across the US starting in 2020, so too did the use of repurposed medications such as hydroxychloroquine and ivermectin to treat COVID-19 infections. Use of these medications ...

America’s FDA leadership has been making decisions based on ideology, not drug safety. It's time for a change of priorities.

Didier Raoult’s research is being called into question Didier Raoult and the hydroxychloroquine controversy ( part 1 ) A census of untruths about chloroquine ( part 2 ) HYDROXYCHLOROQUINE: This is NOT ...

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew ...

Donald Trump has always posed as someone smarter than scientists. Does that explain why so much of his dismantling of the ...

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The situation is causing the FDA regulatory headaches and, more seriously, posing ...

Imagine resurrecting a long-debunked myth, slapping a fresh coat of pseudoscience on it, and dropping it just in time to sway ...